These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 26557005)

  • 41. Ammonia Levels Do Not Guide Clinical Management of Patients With Hepatic Encephalopathy Caused by Cirrhosis.
    Haj M; Rockey DC
    Am J Gastroenterol; 2020 May; 115(5):723-728. PubMed ID: 31658104
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanistic insight, diagnosis, and treatment of ammonia-induced hepatic encephalopathy.
    Fiati Kenston SS; Song X; Li Z; Zhao J
    J Gastroenterol Hepatol; 2019 Jan; 34(1):31-39. PubMed ID: 30070387
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Concise review of current concepts on nomenclature and pathophysiology of hepatic encephalopathy.
    Savlan I; Liakina V; Valantinas J
    Medicina (Kaunas); 2014; 50(2):75-81. PubMed ID: 25172600
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recent insights into the pathogenesis of hepatic encephalopathy and treatments.
    Sturgeon JP; Shawcross DL
    Expert Rev Gastroenterol Hepatol; 2014 Jan; 8(1):83-100. PubMed ID: 24236755
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatic Encephalopathy Aggravated by Systemic Inflammation.
    Manzhalii E; Virchenko O; Falalyeyeva T; Moiseienko V; Nykula T; Kondratiuk V; Savchuk O; Beregova T; Stremmel W
    Dig Dis; 2019; 37(6):509-517. PubMed ID: 31170723
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathophysiology of Hepatic Encephalopathy.
    Jaffe A; Lim JK; Jakab SS
    Clin Liver Dis; 2020 May; 24(2):175-188. PubMed ID: 32245525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of Overt Hepatic Encephalopathy.
    Sussman NL
    Clin Liver Dis; 2015 Aug; 19(3):551-63. PubMed ID: 26195208
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial.
    Lunia MK; Sharma BC; Sharma P; Sachdeva S; Srivastava S
    Clin Gastroenterol Hepatol; 2014 Jun; 12(6):1003-8.e1. PubMed ID: 24246768
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical science workshop: targeting the gut-liver-brain axis.
    Patel VC; White H; Støy S; Bajaj JS; Shawcross DL
    Metab Brain Dis; 2016 Dec; 31(6):1327-1337. PubMed ID: 26446022
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pathogenesis of cirrhotic hepatic encephalopathy. Treatment implications].
    García-Compean D; Michel H
    Rev Gastroenterol Mex; 1995; 60(3):159-68. PubMed ID: 7481451
    [TBL] [Abstract][Full Text] [Related]  

  • 51. L-Carnitine in the treatment of mild or moderate hepatic encephalopathy.
    Malaguarnera M; Pistone G; Astuto M; Dell'Arte S; Finocchiaro G; Lo Giudice E; Pennisi G
    Dig Dis; 2003; 21(3):271-5. PubMed ID: 14571103
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatic encephalopathy in liver cirrhosis: pathogenesis, diagnosis and management.
    Gerber T; Schomerus H
    Drugs; 2000 Dec; 60(6):1353-70. PubMed ID: 11152016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study.
    Sanyal A; Younossi ZM; Bass NM; Mullen KD; Poordad F; Brown RS; Vemuru RP; Mazen Jamal M; Huang S; Merchant K; Bortey E; Forbes WP
    Aliment Pharmacol Ther; 2011 Oct; 34(8):853-61. PubMed ID: 21848797
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Hepatic encephalopathy].
    Festi D; Marasco G; Ravaioli F; Colecchia A
    Recenti Prog Med; 2016 Jul; 107(7):378-85. PubMed ID: 27571468
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
    Maev IV; V'iuchnova ES; Lebedeva EG; Iakovenko EI; Dicheva DT
    Klin Med (Mosk); 2002; 80(5):42-5. PubMed ID: 12087887
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatic encephalopathy in alcoholic cirrhosis.
    Butterworth RF
    Handb Clin Neurol; 2014; 125():589-602. PubMed ID: 25307598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy.
    Sharma P; Sharma BC; Sarin SK
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):526-31. PubMed ID: 20009938
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatic encephalopathy as a complication of liver cirrhosis: an Asian perspective.
    Moriwaki H; Shiraki M; Iwasa J; Terakura Y
    J Gastroenterol Hepatol; 2010 May; 25(5):858-63. PubMed ID: 20546438
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In patients with liver cirrhosis, proinflammatory interleukins correlate with health-related quality of life irrespective of minimal hepatic encephalopathy.
    Wunsch E; Koziarska D; Milkiewicz M; Naprawa G; Nowacki P; Hartleb M; Milkiewicz P
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1402-7. PubMed ID: 24025977
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimal treatment of hepatic encephalopathy.
    Allampati S; Mullen KD
    Minerva Gastroenterol Dietol; 2016 Dec; 62(4):296-304. PubMed ID: 27763575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.